Recent Insider Transactions - 4D Molecular Therapeutics (NASDAQ: FDMT)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ FDMT 4D Molecular Therapeutics

Bizily Scott / officer: Chief Legal Officer

03/06/2025

Buy

$4.14

78,500

$325K

78,500

NASDAQ FDMT 4D Molecular Therapeutics

Kirn David / director, officer: Chief Executive Officer

03/06/2025

Buy

$4.14

267,500

$1.107M

267,500

NASDAQ FDMT 4D Molecular Therapeutics

Kim Robert Young / officer: Chief Medical Officer

03/06/2025

Buy

$4.14

92,300

$382K

92,300

NASDAQ FDMT 4D Molecular Therapeutics

Mehra Uneek / officer: See Remarks

03/06/2025

Buy

$4.14

130,000

$538K

130,000

NASDAQ FDMT 4D Molecular Therapeutics

Kamal Fariborz / officer: President & COO

03/06/2025

Buy

$4.14

178,400

$739K

178,400